Expression and Purification of Optimized rolGLP-1, A Novel GLP-1 Analog, in Escherichia Coli BL21(DE3) and its Good Glucoregulatory Effect on Type 2 Diabetic Mice

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|14|11|985-994

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.14, Iss.11, 2013-11, pp. : 985-994

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Expression of CTB-10×rolGLP-1 in E.coli and Its Therapeutic Effect on Type 2 Diabetes

By  

Current Pharmaceutical Biotechnology, Vol. 16, Iss. 6, 2015-06 ,pp. : 564-572

Bentham Science Publishers

Access to resources Recommend Favorite

Control of Blood Glucose by Novel GLP-1 Delivery Using Biodegradable Triblock Copolymer of PLGA-PEG-PLGA in Type 2 Diabetic Rats

By Choi Suna   Baudys Miroslav   Kim Sung Wan  

Pharmaceutical Research, Vol. 21, Iss. 5, 2004-05 ,pp. : 827-831

Springer Publishing Company

Access to resources Recommend Favorite

Insulin and GLP-1 analog combinations in type 2 diabetes mellitus: a critical review

By Jendle Johan   Martin Sherry A   Milicevic Zvonko  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 10, 2012-10 ,pp. : 1463-1474

Informa Healthcare

Access to resources Recommend Favorite

Exenatide: a GLP-1 receptor agonist as novel therapy for Type 2 diabetes mellitus

By Briones Mariele   Bajaj Mandeep  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 8, 2006-06 ,pp. : 1055-1064

Informa Healthcare

Access to resources Recommend Favorite

GLP-1 agonists for type 2 diabetes: pharmacokinetic and toxicological considerations

By Jespersen Maria J   Knop Filip K   Christensen Mikkel  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 1, 2013-01 ,pp. : 17-29

Informa Healthcare

Access to resources Recommend Favorite